|
시장보고서
상품코드
2075244
암 생검 시장 : 제품 유형별, 생검 유형별Cancer Biopsy Market, By Product, Biopsy Type - |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
암 생검 시장은 2026년에 387억 1,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 1,023억 4,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 14.9%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 387억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 14.90% | 2033년 시장 규모 예측 : | 1,023억 4,000만 달러 |
생검이란 신체에서 조직 조각이나 세포 샘플을 채취하여 검사실에서 검사를 시행하는 의료 검사입니다. 한편, 암 생검에서는 환자의 병변 부위에서 조직이나 세포를 채취하여 암의 유무, 원인 또는 진행 단계를 확인합니다. 이처럼 전 세계에서 암으로 인한 부담이 커짐에 따라 암 생검 시행 건수도 급속히 증가하고 있습니다.
시장 역학 :
암 유병률의 증가, 고령 인구 증가, 액체생검의 등장 및 그 도입 확대, 유전자 검사 및 유전성 암 질환에 대한 대중의 인식 제고, 그리고 생검 기술의 지속적인 발전이 전 세계 암 생검 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어 2022년 5월, 암 조기 발견을 위한 고성능이면서도 합리적인 가격의 새로운 유형의 액체생검 검사를 개발하고 있는 Delfi Diagnostics사는 자사의 차세대 액체생검 플랫폼과 관련된 여러 가지 적용 사례를 발표했습니다. Delfi사는 폐암 검출을 위한 분류기를 훈련 및 검증하는 전향적 사례 대조 연구인 ‘DELFI-L101'에 대해 현재 진행 중인 시험에 관한 최신 정보를 발표했습니다.
본 연구의 주요 특징 :
- 이 연구는 다양한 부문에서 잠재적인 매출 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 보고서에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 암 생검 시장의 주요 업체들을 분석하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 세계의 암 생검 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 암 생검 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 암 생검
제5장 세계의 암 생검 시장 : 제품별, 2021-2033년
제6장 세계의 암 생검 시장 : 생검 유형별, 2021-2033년
제7장 세계의 암 생검 시장 : 용도별, 2021-2033년
제8장 세계의 암 생검 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.08Cancer Biopsy Market is estimated to be valued at USD 38.71 Bn in 2026 and is expected to reach USD 102.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 38.71 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.90% | 2033 Value Projection: | USD 102.34 Bn |
A biopsy is a medical test to remove the piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. While, in cancer biopsy, a tissue or cells of the affected patient is taken to discover the presence, cause, or extent of cancer. Thus, with the rising burden of cancer across the globe, the use of cancer biopsy or cancer biopsies also increasing with a rapid pace.
Market Dynamics:
Increasing prevalence of oncology disorders, growing geriatric population, advent of liquid biopsy or increasing adoption of liquid biopsies, increasing awareness among people about genetic testing and inherited oncology diseases, and ongoing developments in biopsy techniques are major factors expected to augment the growth of the global cancer biopsy market.
For instance, in May 2022, Delfi Diagnostics, a developer of a new class of high-performance and affordable liquid biopsy tests for early cancer detection, presented multiple applications for its next-generation liquid biopsy platform. Delfi presented a trial-in-progress update on DELFI-L101, a prospective, case-control study to train and test classifiers for lung cancer detection.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cancer biopsy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics, COUNSYL, Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cancer biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biopsy market.
Detailed Segmentation:
- Global Cancer Biopsy Market , By Product (Revenue, USD Bn, 2021 - 2033)
- Instruments
- Kits and Consumables
- Services
- Global Cancer Biopsy Market , By Biopsy Type (Revenue, USD Bn, 2021 - 2033)
- Tissue Biopsy
- Needle Biopsy
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
- Needle Biopsy
- Liquid Biopsy
- Others
- Global Cancer Biopsy Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- QIAGEN
- Illumina, Inc.
- Angle PLC
- Myriad Genetics
- COUNSYL, Inc.
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- Hoffmann-La Roche Ltd.
- Epigenomics AG
- BD (Becton, Dickinson and Company)
- Helio Health (Laboratory for Advanced Medicine)
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Biopsy Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising burden of oncology disorders
- Technical and clinical challenges
- Increasing adoption of liquid biopsies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Cancer Biopsy
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Cancer Biopsy Market, By Product, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Kits and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Cancer Biopsy Market, By Biopsy Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Tissue Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Needle Biopsy
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
- Needle Biopsy
- Liquid Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Cancer Biopsy Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cervical Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Skin Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Kidney Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Cancer Biopsy Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
9. Competitive Landscape
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Angle PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- COUNSYL, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocept, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Epigenomics AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BD (Becton, Dickinson and Company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Helio Health (Laboratory for Advanced Medicine)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
